MedPath

The First Affiliated Hospital of Xiamen University

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website
http://www.xmfh.com.cn

Graves' Disease Remission Study: MycoMeth Combo

Phase 2
Recruiting
Conditions
Graves' Disease
Interventions
Drug: methimazole, oral, 10mg
First Posted Date
2023-10-05
Last Posted Date
2024-02-28
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
205
Registration Number
NCT06068179
Locations
🇨🇳

Xiao Fangsen, Xiamen, Fujian, China

APA on Sleep Quality in Women With PCOS

Not Applicable
Completed
Conditions
Polycystic Ovary Syndrome
Interventions
Other: Auricular point acupressure (APA)
First Posted Date
2023-08-24
Last Posted Date
2023-08-28
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
88
Registration Number
NCT06009172
Locations
🇨🇳

Department of Endocrinology and Diabetes, the First Affiliated Hospital of Xiamen University, School of medicine, Xiamen university, Xiamen, China, Xiamen, Fujian, China

Characterizing Spondyloarthritis With 68Ga-FAPI PET/CT

Not Applicable
Recruiting
Conditions
Ankylosing Spondylitis
Axial Spondyloarthritis
Spondyloarthritis
First Posted Date
2023-08-21
Last Posted Date
2023-08-21
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
50
Registration Number
NCT05999643
Locations
🇨🇳

The first affiliated hospital of Xiamen University, Xiamen, Fujian, China

Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma

Phase 2
Recruiting
Conditions
Hepatocellular Carcinoma
Adebrelimab
Transformation
Bevacizumab
TACE
Interventions
First Posted Date
2023-08-01
Last Posted Date
2024-02-28
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
71
Registration Number
NCT05970666
Locations
🇨🇳

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

Clinical Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Various Solid Tumors

Phase 2
Completed
Conditions
Refractory Solid Tumor
Interventions
Drug: 177Lu-DOTA-EB-FAPI radionuclide therapy
First Posted Date
2023-07-27
Last Posted Date
2025-03-28
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
28
Registration Number
NCT05963386
Locations
🇨🇳

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

Characterizing Myositis With 68Ga-FAPI PET/CT

Early Phase 1
Recruiting
Conditions
Myositis
Idiopathic Inflammatory Myopathies
Interventions
First Posted Date
2023-07-19
Last Posted Date
2023-07-19
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
50
Registration Number
NCT05952531
Locations
🇨🇳

The first affiliated hospital of Xiamen University, Xiamen, Fujian, China

68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG

Not Applicable
Recruiting
Conditions
SSTR2
FAP
Positron-Emission Tomography
Interventions
Diagnostic Test: 18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT
First Posted Date
2023-05-24
Last Posted Date
2023-05-26
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
30
Registration Number
NCT05873777
Locations
🇨🇳

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

Pulmonary Vein Isolation (PVI) Combined With Renal Denervation (RDN) in Atrial Fibrillation (AF) and Hypertension (HTN)

Not Applicable
Recruiting
Conditions
HTN-Hypertension
AF - Atrial Fibrillation
Interventions
Other: Renal Denervation operation
Other: Pulmonary vein isolation
First Posted Date
2023-05-03
Last Posted Date
2024-03-13
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
120
Registration Number
NCT05841615
Locations
🇨🇳

the first affiliated hopital of Xiamen University, Xiamen, Fujian, China

A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer

Recruiting
Conditions
Ovarian Cancer
First Posted Date
2023-04-21
Last Posted Date
2023-04-21
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
60
Registration Number
NCT05824247
Locations
🇨🇳

First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

Individualized Precision Treatment Based on Ovarian Cancer Organoid Model

Not Applicable
Recruiting
Conditions
Ovarian Cancer
Interventions
Device: Organoid culture
First Posted Date
2023-04-14
Last Posted Date
2023-04-14
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
30
Registration Number
NCT05813509
Locations
🇨🇳

First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

© Copyright 2025. All Rights Reserved by MedPath